Renal effects of ibuprofen for the treatment of patent ductus arteriosus in premature infants

References

• Cotton R B, Stahlman M T, Kovar I, Catteron W Z. Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr 1978; 92: 467–473
   PubMed Web of Science ®Google Scholar
• Stefano J L, Abbasi S, Pearlman S A, Spear M L, Esterly K L, Bhutani V K. Closure of ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome: Effects on pulmonary compliance and ventilation. Am Rev Respir Dis 1991; 143: 236–239
   PubMed Web of Science ®Google Scholar
• Coombs R C, Morgan M E, Durbin G M, Booth I W, McNeish A S. Gut blood flow velocities in the newborn: Effects of the patent ductus arteriosus and parenteral indomethacin. Arch Dis Child 1990; 65: 1067–1070
   PubMed Web of Science ®Google Scholar
• Van Bel F, Van der Bor M, Stijnen T, Baan J, Ruys J H. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: Duration of its effects. Pediatrics 1989; 84: 802–807
   PubMed Web of Science ®Google Scholar
• Van Bel F, Van Zoeren D, Shipper J, Guit G L, Baan J. Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants. J Pediatr 1990; 116: 965–970
   PubMed Web of Science ®Google Scholar
• Yeh T F, Wilks A, Singh J, Betkerur M, Lilien L, Phildes R S. Furosemide prevents renal side effects of indomethacin therapy in preterm infants with persistent ductus arteriosus. J Pediatr 1982; 101: 433–437
   PubMed Web of Science ®Google Scholar
• Fajardo C A, Whyte R K, Steele B T. Effect of dopamine on failure of indomethacin to close the patent ductus arteriosus. J Pediatr 1992; 121: 771–775
   PubMed Web of Science ®Google Scholar
• Rennie J M, Cooke R W. Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. Arch Dis Child 1991; 66: 55–58
   PubMed Web of Science ®Google Scholar
• Hammerman C, Aramburo M J. Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. J Pediatr 1990; 117: 771–776
   PubMed Web of Science ®Google Scholar
• Sakhalkar V S, Merchant R H. Therapy of symptomatic patent ductus arteriosus in preterms using mefenamic acid and indomethacin. Indian Pediatr 1992; 29: 313–318
   PubMedGoogle Scholar
• Van Overmeire B, Brus F, Van Acker K J, Van Der Auwera J C, Schasfoort M, Elzenga N J. Aspirin versus indomethacin treatment of patent ductus arteriosus in the preterm neonate with respiratory distress syndrome. Pediatr Res 1995; 38: 886–891
   PubMed Web of Science ®Google Scholar
• Fanos V, Benini D, Verlato G, Errico G, Cuzzolin L. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus. Fundam Clin Pharmacol 2004; 19: 187–193
   Web of Science ®Google Scholar
• Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, Saia O S. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: A randomised controlled trial. Eur J Pediatr 2002; 161: 202–207
   PubMed Web of Science ®Google Scholar
• Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K, Langhendries J P. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343: 674–681
   PubMed Web of Science ®Google Scholar
• Gournay V, Roze J C, Kuster A, Daoud P, Cambonie G, Hascoet J M, Chamboux C, Blanc T, Fichtner C, Savagner C, Gouyoh J B, Flurin V, Thiriez G, et al. Prophylactic ibuprofen versus placebo in very premature infants: A randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1939–1944
   PubMed Web of Science ®Google Scholar
• Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwé W, Jespers A, Weyler J, Harrewijn I, Langhendries J P, et al. Prophylactic ibuprofen in premature infants: A multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1945–1949
   PubMed Web of Science ®Google Scholar
• Krueger E, Mellander M, Bratton D, Cotton R. Prevention of symptomatic ductus arteriosus with a single dose of indomethacin. J Pediatr 1987; 111: 749–754
   PubMed Web of Science ®Google Scholar
• Hammerman C, Glaser J, Schimmel M S, Ferber B, Kaplan M, Eidelman A I. Continuous versus multiple rapid infusions of indomethacin: Effects on cerebral blood flow velocity. Pediatrics 1995; 95: 244–248
   PubMed Web of Science ®Google Scholar
• Clyman R I. Recommendations for the postnatal use of indomethacin: An analysis of four separate treatment strategies. J Pediatr 1996; 128: 601–607
   PubMed Web of Science ®Google Scholar
• Chemtob S, Beharry K, Barna T, Varma D R, Aranda J V. Differences in the effects in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatr Res 1991; 30: 106–111
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2005, 4, CD003481
   Web of Science ®Google Scholar
• Austin N C, Pairaudeau P W, Hames T K, Hall M A. Regional blood flow velocity changes after indomethacin infusion in preterm infants. Arch Dis Child 1992; 67: 851–854
   PubMed Web of Science ®Google Scholar
• Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997; 131: 549–554
   PubMed Web of Science ®Google Scholar
• Malcolm D D, Segar J L, Robillard J E, Chemtob S. Indomethacin compromises hemodynamics during positive-pressure ventilation, independently of prostanoids. J Appl Physiol 1993; 74: 1672–1678
   PubMed Web of Science ®Google Scholar
• Van Overmeire B, Follens I, Hartmann S, Creten W L, Van Aker K J. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child 1997; 76: 179–184
   Web of Science ®Google Scholar
• Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli F F. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999; 135: 733–738
   PubMed Web of Science ®Google Scholar
• Van Bel F, Guit G L, Schipper J, Guit G L, van der Bor M, Baan J. Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr 1991; 118: 621–626
   PubMed Web of Science ®Google Scholar
• Guignard J P. The adverse renal effects of prostaglandin synthesis inhibitors in the newborn rabbit. Semin Perinatol 2002; 26: 398–405
   PubMed Web of Science ®Google Scholar
• Allegaert K, Vanhole C, de Hoon J, Guignard J P, Tibboel D, Devlieger H, Van Overmeire B. Nonselective cyclo-oxygenase inhibitors and glomerular filtration rate in preterm neonates. Pediatr Nephrol 2005; 20: 1557–1561
   PubMed Web of Science ®Google Scholar
• Guignard J P. Renal function in the newborn infant. Pediatr Clin North Am 1982; 29: 777–790
   PubMed Web of Science ®Google Scholar
• Simeoni U, Matis J, Messer J. Clinical implications of renal immaturity in tiny, premature infants. Neonatal nephrology in progress, L Cataldi, V Fanos, U Simeoni. Agora, Lecce 1996; 129–140
   Google Scholar
• Gouyon J B, Guignard J P, Simeoni U. Néphrologie périnatale. Vol. 1. Equilibre hydro-électrolytique du grand prématuré. Arnette, Paris 1997
   Google Scholar
• Smith G C. The pharmacology of the ductus arteriosus. Pharmacol Rev 1998; 50: 35–38
   PubMed Web of Science ®Google Scholar
• Koren G, James A, Perlman M. A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn. Clin Pharmacol Ther 1985; 38: 680–685
   PubMed Web of Science ®Google Scholar
• Simeoni U, Messer J, Weisburd P, Haddad J, Willard D. Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors. Eur J Pediatr 1989; 148: 371–373
   PubMed Web of Science ®Google Scholar
• Knight D B. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001; 6: 63–73
   PubMedGoogle Scholar
• Novy M J. Effects of indomethacin on labor, fetal oxygenation and fetal development in rhesus monkeys. Adv Prostaglandin Thromboxane Res 1978; 4: 287–300
   Google Scholar
• Wyllie J. Treatment of patent ductus arteriosus. Semin Neonatol 2003; 8: 425–432
   PubMedGoogle Scholar
• Coceani F, Olley P M. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol 1973; 51: 220–225
   PubMed Web of Science ®Google Scholar
• Clyman R I, Mauray F, Roman C, Rudolph A M. PGE2 is a more potent vasodilator of the lamb ductus arteriosus than is either PGI2 or 6 keto PGF1alpha. Prostaglandins 1978; 16: 259–264
   PubMed Web of Science ®Google Scholar
• Coceani F, Bishai I, White E, Bodach, Olley P M. Action of prostaglandins, endoperoxides, and thromboxanes on the lamb ductus arteriosus. Am J Physiol 1978; 234: 117–122
   Google Scholar
• Smith G C, Coleman R A, McGrath J C. Characterization of dilator prostanoid receptors in the fetal rabbit ductus arteriosus. J Pharmacol Exp Ther 1994; 271: 390–396
   PubMed Web of Science ®Google Scholar
• Seyberth H W, Muller H, Ulmer H E, Willie L. Urinary excretion rates of 6-keto-PGF1 alpha in preterm infants recovering from respiratory distress with and without patent ductus arteriosus. Pediatr Res 1984; 18: 520–524
   PubMed Web of Science ®Google Scholar
• Leonhardt A, Glaser A, Wegmann M, Schranz D, Seyberth H, Nusing R. Expression of prostanoid receptors in human ductus arteriosus. Br J Pharmacol 2003; 138: 655–659
   PubMed Web of Science ®Google Scholar
• Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: Structures, properties, and functions. Physiol Rev 1999; 79: 1193–1226
   PubMed Web of Science ®Google Scholar
• Bouayad A, Kajino H, Waleh N, Fouron J C, Andelfinger G, Varma D R, Skoll A, Vazquez A, Gobeil J RF, Clyman R I, et al. Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus. Am J Physiol Heart Circ Physiol 2001; 280: 2342–2349
   PubMed Web of Science ®Google Scholar
• Bhattacharya M, Asselin P, Hardy P, Guerguerian A M, Shichi H, Hou X, Varma D R, Bouayad A, Fouron J C, Clyman R I, et al. Developmental changes in prostaglandin E(2) receptor subtypes in porcine ductus arteriosus. Possible contribution in altered responsiveness to prostaglandin E(2). Circulation 1999; 100: 1751–1756
   PubMed Web of Science ®Google Scholar
• Nguyen M T, Camenisch T, Snowaert J N, Hicks E, Coffman T M, Anderson P A, Malouf M N, Koller B H. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 1997; 390: 78–81
   PubMed Web of Science ®Google Scholar
• Wright D H, Abran D, Bhattacharya M, Hou X, Bernier S G, Bouayad A, Fouron J C, Vazquez-Tello A, Beauchamp M H, Clyman R I, et al. Prostanoid receptors: Ontogeny and implications in vascular physiology. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1343–R1360
   Web of Science ®Google Scholar
• Dinchuk J E, Car B D, Focht R J, Johnston J J, Jaffee B D, Covington M B, Contel N R, Eng V M, Collins R J, Czerniak P M, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995; 378: 406–409
   PubMed Web of Science ®Google Scholar
• Clive D M, Stoff J S. Renal syndromes associated with non-steroidal antiinflamatory drugs. N Engl J Med 1984; 310: 563–572
   PubMed Web of Science ®Google Scholar
• Morham S G, Langenbach R, Loftin C D, Tiano H F, Vouloumanos N, Jennette J C, Mahler J F, Kluckman K D, Ledford A, Lee C A, Smithies O, et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995; 83: 473–482
   PubMed Web of Science ®Google Scholar
• Veersema D, de Jong P A, van Wijck J A. Indomethacin and the fetal nonfunction syndrome. Eur J Obstet Gynecol Reprod Biol 1983; 16: 113–121
   PubMed Web of Science ®Google Scholar
• Adams S S, Bresloff P, Mason C G. Pharmacological differences between the optical isomers of ibuprofen: Evidence for metabolic inversion of the (−)-isomer. J Pharm Pharmacol 1976; 28: 256–257
   PubMed Web of Science ®Google Scholar
• Brocks D R, Jamali F. The pharmacokinetics of ibuprofen in humans and animals. Ibuprofen: A critical bibliographic review, K D Rainsford. Taylor and Francis, London 1999; 87–142
   Google Scholar
• Coceani F, White E, Bodach E, Olley P M. Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen. Can J Physiol Pharmacol 1979; 57: 825–831
   PubMed Web of Science ®Google Scholar
• Feigen L P, King L W, Ray J, Beckett W, Kadowitz P J. Differential effects of ibuprofen and indomethacin in the regional circulation of the dog. J Pharmacol Exp Ther 1981; 219: 679–684
   PubMed Web of Science ®Google Scholar
• Grosfeld J L, Kamman K, Gross K Cikrit D, Ross D, Wolfe M, Katz S, Weber T R. Comparative effects of indomethacin, prostaglandin E1, and ibuprofen on bowel ischemia. J Pediatr Surg 1983; 18: 738–742
   PubMed Web of Science ®Google Scholar
• Rao P S, Cavanagh D, Dietz J R. Renal effects of intermittent versus continuous infusion of ibuprofen in the primate. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 249–256
   PubMed Web of Science ®Google Scholar
• Winslow C, Dorinsky P M. Regional blood flow distribution in endotoxin-treated dogs: Modification by ibuprofen. J Crit Care 1994; 9: 159–168
   PubMed Web of Science ®Google Scholar
• Touw D J. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes. Drug Metabol Drug Interact 1997; 14: 55–82
   PubMedGoogle Scholar
• Van Overmeire B, Touw D, Schepens P, Kearns G L, van den Anker J N. Ibuprofen in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther 2001; 70: 336–343
   PubMed Web of Science ®Google Scholar
• Kauffman R E, Nelson M V. Effect of age on ibuprofen pharmacokinetics and antipyretic response. J Pediatr 1992; 121: 969–973
   PubMed Web of Science ®Google Scholar
• Patel J, Marks K A, Roberts I, Azzopardi D, Edwards A D, et al. Ibuprofen treatment of patent ductus arteriosus. Lancet 1995; 346: 255
   PubMed Web of Science ®Google Scholar
• Su P H, Chen J Y, Su C M, Huang T C, Lee H S. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int 2003; 45: 665–670
   PubMed Web of Science ®Google Scholar
• Gimeno Navarro A, Cano Sanchez A, Fernandez Gilino C, Carrasco Moreno J I, Izquierdo Macian I, Gutierrez Laso A, Morcillo Sopena F. Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants. Ann Pediatr (Barc) 2005; 63: 212–218
   PubMedGoogle Scholar
• Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2003, 2, CD003481
   Google Scholar
• Thomas R L, Aranda J V, Van Overmeire B, Hamre M. A meta-analysis comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005; 164: 135–140
   PubMed Web of Science ®Google Scholar
• Fowlie P W, Davis P G. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002, 3, CD000174
   Google Scholar
• Varvarigou A, Bardin C L, Beharry K, Chemtob S, Papageorgiou A, Aranda J V. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996; 275: 539–544
   PubMed Web of Science ®Google Scholar
• De Carolis M P, Romagnoli C, Polimeni V, Piersigilli F, Zecca E, Papacci P, Delogu A B, Tortorolo G, et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr 2000; 59: 364–368
   Google Scholar
• Dani C, Bertini G, Reali M F, Murru P, Fabris C, Vangi V, Rubaltelli F F. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Paediatr 2000; 89: 1369–1374
   PubMed Web of Science ®Google Scholar
• Romagnoli C, De Carolis M P, Papacci P, Polimeni V, Luciano R, Piersigilli F, Delogu A B, Tortorolo G. Effects of prophylactic ibuprofen on cerebral and renal hemodynamics in very preterm neonates. Clin Pharmacol Ther 2000; 67: 676–683
   PubMed Web of Science ®Google Scholar
• Naulaers G, Delanghe G, Allegaert K, Debeer A, Cossey V, Vanhole C, Casaer P, Devlieger H, Van Overmeire B. Ibuprofen and cerebral oxygenation and circulation. Arch Dis Child Fetal Neonatal Ed 2005; 90: 75–76
   Web of Science ®Google Scholar
• Shah S S, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2003, 2, CD004213
   Google Scholar
• Gournay V, Savagner C, Thiriez G, Kuster A, Rozé J C. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002; 359: 1486–1488
   PubMed Web of Science ®Google Scholar
• Speziale M V, Allen R G, Henderson C R, Barrington K J, Finer N N. Effects of ibuprofen and indomethacin on regional circulation in newborn piglets. Biol Neonate 1999; 76: 242–252
   PubMedGoogle Scholar
• Zanardo V, Vedovato S, Lago P, Piva D, Faggian D, Chiozza L. Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus. Fetal Diagn Ther 2005; 20: 534–539
   PubMed Web of Science ®Google Scholar
• Walker M P, Moore T R, Brace R A. Indomethacin and arginine vasopressin interaction in the fetal kidney: A mechanism of oliguria. Am J Obstet Gynecol 1994; 171: 1234–1241
   PubMed Web of Science ®Google Scholar
• Ronconi M, Fortunato A, Soffiati G, Zacchello G, Zanardo V. Vasopressin, atrial natriuretic factor and renal water homeostasis in premature newborn infants with respiratory distress syndrome. J Perinat Med 1995; 23: 307–314
   PubMed Web of Science ®Google Scholar
• Zanardo V, Vedovato S, Lago P, Trevisanuto D, Favaro F, Faggian D, Plebani M. Urinary ET-1, AVP and sodium in premature infants treated with indomethacin and ibuprofen for patent ductus arteriosus. Pediatr Nephrol 2005; 20: 1552–1556
   PubMed Web of Science ®Google Scholar
• Brooks D P, Share L, Crofton J T. Role of brain prostaglandins in the control of vasopressin secretion in the conscious rat. Endocrinology 1986; 118: 1716–1722
   PubMed Web of Science ®Google Scholar
• Chamaa N S, Mosig D, Drukker A, Guignard J P. The renal hemodynamic effects of ibuprofen in the newborn rabbit. Pediatr Res 2000; 48: 600–605
   PubMed Web of Science ®Google Scholar
• Hammerman C, Kaplan M. Primum non nocere: Prophylactic versus curative ibuprofen. Lancet 2004; 36: 1920–1922
   Google Scholar